Investors Target AEVEX Corp. Over Alleged IPO Lock-Up Deception

The litigation, spearheaded by Robbins LLP, targets stock acquisitions made between the company’s April 17, 2026, initial public offering and June 4, 2026. Plaintiffs contend that AEVEX and its primary stakeholder, the Chicago-based private equity firm Madison, misrepresented the company’s commitment to a 180-day moratorium on share sales. While investors were led to believe that Madison—which held 77.5% of AEVEX stock post-IPO—would remain restricted until mid-October, the suit claims a pre-arranged plan enabled a secondary public offering (SPO) just weeks after the company went public.

This maneuver resulted in the sale of eight million shares, generating over $200 million for Madison and more than $8 million in fees for the underwriters. Market reaction was immediate and severe: the share price plummeted 16% on June 2, 2026, following the initial SPO registration, and dipped an additional 7% on June 5 after the final prospectus emerged. These two events collectively erased roughly $900 million in market capitalization. Investors who sustained losses during this period have until October 20, 2026, to apply for lead plaintiff status in the ongoing proceedings.